The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inhaled NO Vasodilator Market Research Report 2025
Synopsis
Inhaled NO Vasodilator is a medical treatment used to dilate blood vessels and improve blood flow in conditions like pulmonary hypertension. Inhaled nitric oxide is delivered via a specialized device that allows patients to breathe in the gas, leading to relaxation of blood vessel walls and enhanced oxygen exchange in the lungs.
The global Inhaled NO Vasodilator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Inhaled NO Vasodilator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled NO Vasodilator.
Report Scope
The Inhaled NO Vasodilator market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled NO Vasodilator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled NO Vasodilator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others
Segment by Application
PPHN
ARDS
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled NO Vasodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled NO Vasodilator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inhaled NO Vasodilator is a medical treatment used to dilate blood vessels and improve blood flow in conditions like pulmonary hypertension. Inhaled nitric oxide is delivered via a specialized device that allows patients to breathe in the gas, leading to relaxation of blood vessel walls and enhanced oxygen exchange in the lungs.
The global Inhaled NO Vasodilator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Inhaled NO Vasodilator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled NO Vasodilator.
Report Scope
The Inhaled NO Vasodilator market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled NO Vasodilator market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled NO Vasodilator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others
Segment by Application
PPHN
ARDS
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled NO Vasodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled NO Vasodilator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inhaled NO Vasodilator Market Overview
1.1 Product Overview and Scope of Inhaled NO Vasodilator
1.2 Inhaled NO Vasodilator Segment by Type
1.2.1 Global Inhaled NO Vasodilator Market Value Comparison by Type (2024-2030)
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Inhaled NO Vasodilator Segment by Application
1.3.1 Global Inhaled NO Vasodilator Market Value by Application: (2024-2030)
1.3.2 PPHN
1.3.3 ARDS
1.3.4 Others
1.4 Global Inhaled NO Vasodilator Market Size Estimates and Forecasts
1.4.1 Global Inhaled NO Vasodilator Revenue 2019-2030
1.4.2 Global Inhaled NO Vasodilator Sales 2019-2030
1.4.3 Global Inhaled NO Vasodilator Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inhaled NO Vasodilator Market Competition by Manufacturers
2.1 Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inhaled NO Vasodilator Average Price by Manufacturers (2019-2024)
2.4 Global Inhaled NO Vasodilator Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled NO Vasodilator, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled NO Vasodilator, Product Type & Application
2.7 Inhaled NO Vasodilator Market Competitive Situation and Trends
2.7.1 Inhaled NO Vasodilator Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inhaled NO Vasodilator Players Market Share by Revenue
2.7.3 Global Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaled NO Vasodilator Retrospective Market Scenario by Region
3.1 Global Inhaled NO Vasodilator Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inhaled NO Vasodilator Global Inhaled NO Vasodilator Sales by Region: 2019-2030
3.2.1 Global Inhaled NO Vasodilator Sales by Region: 2019-2024
3.2.2 Global Inhaled NO Vasodilator Sales by Region: 2025-2030
3.3 Global Inhaled NO Vasodilator Global Inhaled NO Vasodilator Revenue by Region: 2019-2030
3.3.1 Global Inhaled NO Vasodilator Revenue by Region: 2019-2024
3.3.2 Global Inhaled NO Vasodilator Revenue by Region: 2025-2030
3.4 North America Inhaled NO Vasodilator Market Facts & Figures by Country
3.4.1 North America Inhaled NO Vasodilator Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inhaled NO Vasodilator Sales by Country (2019-2030)
3.4.3 North America Inhaled NO Vasodilator Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhaled NO Vasodilator Market Facts & Figures by Country
3.5.1 Europe Inhaled NO Vasodilator Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inhaled NO Vasodilator Sales by Country (2019-2030)
3.5.3 Europe Inhaled NO Vasodilator Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled NO Vasodilator Market Facts & Figures by Country
3.6.1 Asia Pacific Inhaled NO Vasodilator Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inhaled NO Vasodilator Sales by Country (2019-2030)
3.6.3 Asia Pacific Inhaled NO Vasodilator Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inhaled NO Vasodilator Market Facts & Figures by Country
3.7.1 Latin America Inhaled NO Vasodilator Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inhaled NO Vasodilator Sales by Country (2019-2030)
3.7.3 Latin America Inhaled NO Vasodilator Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled NO Vasodilator Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled NO Vasodilator Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inhaled NO Vasodilator Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inhaled NO Vasodilator Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhaled NO Vasodilator Sales by Type (2019-2030)
4.1.1 Global Inhaled NO Vasodilator Sales by Type (2019-2024)
4.1.2 Global Inhaled NO Vasodilator Sales by Type (2025-2030)
4.1.3 Global Inhaled NO Vasodilator Sales Market Share by Type (2019-2030)
4.2 Global Inhaled NO Vasodilator Revenue by Type (2019-2030)
4.2.1 Global Inhaled NO Vasodilator Revenue by Type (2019-2024)
4.2.2 Global Inhaled NO Vasodilator Revenue by Type (2025-2030)
4.2.3 Global Inhaled NO Vasodilator Revenue Market Share by Type (2019-2030)
4.3 Global Inhaled NO Vasodilator Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inhaled NO Vasodilator Sales by Application (2019-2030)
5.1.1 Global Inhaled NO Vasodilator Sales by Application (2019-2024)
5.1.2 Global Inhaled NO Vasodilator Sales by Application (2025-2030)
5.1.3 Global Inhaled NO Vasodilator Sales Market Share by Application (2019-2030)
5.2 Global Inhaled NO Vasodilator Revenue by Application (2019-2030)
5.2.1 Global Inhaled NO Vasodilator Revenue by Application (2019-2024)
5.2.2 Global Inhaled NO Vasodilator Revenue by Application (2025-2030)
5.2.3 Global Inhaled NO Vasodilator Revenue Market Share by Application (2019-2030)
5.3 Global Inhaled NO Vasodilator Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt
6.1.1 Mallinckrodt Corporation Information
6.1.2 Mallinckrodt Description and Business Overview
6.1.3 Mallinckrodt Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Inhaled NO Vasodilator Product Portfolio
6.1.5 Mallinckrodt Recent Developments/Updates
6.2 Praxair (Linde plc)
6.2.1 Praxair (Linde plc) Corporation Information
6.2.2 Praxair (Linde plc) Description and Business Overview
6.2.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio
6.2.5 Praxair (Linde plc) Recent Developments/Updates
6.3 Air Liquide
6.3.1 Air Liquide Corporation Information
6.3.2 Air Liquide Description and Business Overview
6.3.3 Air Liquide Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Air Liquide Inhaled NO Vasodilator Product Portfolio
6.3.5 Air Liquide Recent Developments/Updates
6.4 BOC Healthcare (Linde Group)
6.4.1 BOC Healthcare (Linde Group) Corporation Information
6.4.2 BOC Healthcare (Linde Group) Description and Business Overview
6.4.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio
6.4.5 BOC Healthcare (Linde Group) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled NO Vasodilator Industry Chain Analysis
7.2 Inhaled NO Vasodilator Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled NO Vasodilator Production Mode & Process
7.4 Inhaled NO Vasodilator Sales and Marketing
7.4.1 Inhaled NO Vasodilator Sales Channels
7.4.2 Inhaled NO Vasodilator Distributors
7.5 Inhaled NO Vasodilator Customers
8 Inhaled NO Vasodilator Market Dynamics
8.1 Inhaled NO Vasodilator Industry Trends
8.2 Inhaled NO Vasodilator Market Drivers
8.3 Inhaled NO Vasodilator Market Challenges
8.4 Inhaled NO Vasodilator Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Inhaled NO Vasodilator Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Inhaled NO Vasodilator Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Inhaled NO Vasodilator Market Competitive Situation by Manufacturers in 2023
Table 4. Global Inhaled NO Vasodilator Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Inhaled NO Vasodilator Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Inhaled NO Vasodilator Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Inhaled NO Vasodilator Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Inhaled NO Vasodilator, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inhaled NO Vasodilator, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhaled NO Vasodilator, Product Type & Application
Table 12. Global Key Manufacturers of Inhaled NO Vasodilator, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaled NO Vasodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled NO Vasodilator as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaled NO Vasodilator Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Inhaled NO Vasodilator Sales by Region (2019-2024) & (K Units)
Table 18. Global Inhaled NO Vasodilator Sales Market Share by Region (2019-2024)
Table 19. Global Inhaled NO Vasodilator Sales by Region (2025-2030) & (K Units)
Table 20. Global Inhaled NO Vasodilator Sales Market Share by Region (2025-2030)
Table 21. Global Inhaled NO Vasodilator Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Inhaled NO Vasodilator Revenue Market Share by Region (2019-2024)
Table 23. Global Inhaled NO Vasodilator Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Inhaled NO Vasodilator Revenue Market Share by Region (2025-2030)
Table 25. North America Inhaled NO Vasodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Inhaled NO Vasodilator Sales by Country (2019-2024) & (K Units)
Table 27. North America Inhaled NO Vasodilator Sales by Country (2025-2030) & (K Units)
Table 28. North America Inhaled NO Vasodilator Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Inhaled NO Vasodilator Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Inhaled NO Vasodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Inhaled NO Vasodilator Sales by Country (2019-2024) & (K Units)
Table 32. Europe Inhaled NO Vasodilator Sales by Country (2025-2030) & (K Units)
Table 33. Europe Inhaled NO Vasodilator Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Inhaled NO Vasodilator Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Inhaled NO Vasodilator Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Inhaled NO Vasodilator Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Inhaled NO Vasodilator Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Inhaled NO Vasodilator Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Inhaled NO Vasodilator Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inhaled NO Vasodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Inhaled NO Vasodilator Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Inhaled NO Vasodilator Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Inhaled NO Vasodilator Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Inhaled NO Vasodilator Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Inhaled NO Vasodilator Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Inhaled NO Vasodilator Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Inhaled NO Vasodilator Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Inhaled NO Vasodilator Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inhaled NO Vasodilator Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Inhaled NO Vasodilator Sales (K Units) by Type (2019-2024)
Table 51. Global Inhaled NO Vasodilator Sales (K Units) by Type (2025-2030)
Table 52. Global Inhaled NO Vasodilator Sales Market Share by Type (2019-2024)
Table 53. Global Inhaled NO Vasodilator Sales Market Share by Type (2025-2030)
Table 54. Global Inhaled NO Vasodilator Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Inhaled NO Vasodilator Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Inhaled NO Vasodilator Revenue Market Share by Type (2019-2024)
Table 57. Global Inhaled NO Vasodilator Revenue Market Share by Type (2025-2030)
Table 58. Global Inhaled NO Vasodilator Price (US$/Unit) by Type (2019-2024)
Table 59. Global Inhaled NO Vasodilator Price (US$/Unit) by Type (2025-2030)
Table 60. Global Inhaled NO Vasodilator Sales (K Units) by Application (2019-2024)
Table 61. Global Inhaled NO Vasodilator Sales (K Units) by Application (2025-2030)
Table 62. Global Inhaled NO Vasodilator Sales Market Share by Application (2019-2024)
Table 63. Global Inhaled NO Vasodilator Sales Market Share by Application (2025-2030)
Table 64. Global Inhaled NO Vasodilator Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Inhaled NO Vasodilator Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Inhaled NO Vasodilator Revenue Market Share by Application (2019-2024)
Table 67. Global Inhaled NO Vasodilator Revenue Market Share by Application (2025-2030)
Table 68. Global Inhaled NO Vasodilator Price (US$/Unit) by Application (2019-2024)
Table 69. Global Inhaled NO Vasodilator Price (US$/Unit) by Application (2025-2030)
Table 70. Mallinckrodt Corporation Information
Table 71. Mallinckrodt Description and Business Overview
Table 72. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Mallinckrodt Inhaled NO Vasodilator Product
Table 74. Mallinckrodt Recent Developments/Updates
Table 75. Praxair (Linde plc) Corporation Information
Table 76. Praxair (Linde plc) Description and Business Overview
Table 77. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Praxair (Linde plc) Inhaled NO Vasodilator Product
Table 79. Praxair (Linde plc) Recent Developments/Updates
Table 80. Air Liquide Corporation Information
Table 81. Air Liquide Description and Business Overview
Table 82. Air Liquide Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Air Liquide Inhaled NO Vasodilator Product
Table 84. Air Liquide Recent Developments/Updates
Table 85. BOC Healthcare (Linde Group) Corporation Information
Table 86. BOC Healthcare (Linde Group) Description and Business Overview
Table 87. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product
Table 89. BOC Healthcare (Linde Group) Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Inhaled NO Vasodilator Distributors List
Table 93. Inhaled NO Vasodilator Customers List
Table 94. Inhaled NO Vasodilator Market Trends
Table 95. Inhaled NO Vasodilator Market Drivers
Table 96. Inhaled NO Vasodilator Market Challenges
Table 97. Inhaled NO Vasodilator Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhaled NO Vasodilator
Figure 2. Global Inhaled NO Vasodilator Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Inhaled NO Vasodilator Market Share by Type in 2023 & 2030
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled NO Vasodilator Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Inhaled NO Vasodilator Market Share by Application in 2023 & 2030
Figure 9. PPHN
Figure 10. ARDS
Figure 11. Others
Figure 12. Global Inhaled NO Vasodilator Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Inhaled NO Vasodilator Market Size (2019-2030) & (US$ Million)
Figure 14. Global Inhaled NO Vasodilator Sales (2019-2030) & (K Units)
Figure 15. Global Inhaled NO Vasodilator Average Price (US$/Unit) & (2019-2030)
Figure 16. Inhaled NO Vasodilator Report Years Considered
Figure 17. Inhaled NO Vasodilator Sales Share by Manufacturers in 2023
Figure 18. Global Inhaled NO Vasodilator Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Inhaled NO Vasodilator Players: Market Share by Revenue in 2023
Figure 20. Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Inhaled NO Vasodilator Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Inhaled NO Vasodilator Sales Market Share by Country (2019-2030)
Figure 23. North America Inhaled NO Vasodilator Revenue Market Share by Country (2019-2030)
Figure 24. United States Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Inhaled NO Vasodilator Sales Market Share by Country (2019-2030)
Figure 27. Europe Inhaled NO Vasodilator Revenue Market Share by Country (2019-2030)
Figure 28. Germany Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Inhaled NO Vasodilator Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Inhaled NO Vasodilator Revenue Market Share by Region (2019-2030)
Figure 35. China Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Inhaled NO Vasodilator Sales Market Share by Country (2019-2030)
Figure 45. Latin America Inhaled NO Vasodilator Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Inhaled NO Vasodilator Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Inhaled NO Vasodilator Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Inhaled NO Vasodilator Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Inhaled NO Vasodilator by Type (2019-2030)
Figure 55. Global Revenue Market Share of Inhaled NO Vasodilator by Type (2019-2030)
Figure 56. Global Inhaled NO Vasodilator Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Inhaled NO Vasodilator by Application (2019-2030)
Figure 58. Global Revenue Market Share of Inhaled NO Vasodilator by Application (2019-2030)
Figure 59. Global Inhaled NO Vasodilator Price (US$/Unit) by Application (2019-2030)
Figure 60. Inhaled NO Vasodilator Value Chain
Figure 61. Inhaled NO Vasodilator Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
